These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29446003)

  • 1. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for assessing the preventability of adverse drug events: a systematic review.
    Hakkarainen KM; Andersson Sundell K; Petzold M; Hägg S
    Drug Saf; 2012 Feb; 35(2):105-26. PubMed ID: 22201475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.
    Hug BL; Witkowski DJ; Sox CM; Keohane CA; Seger DL; Yoon C; Matheny ME; Bates DW
    J Gen Intern Med; 2010 Jan; 25(1):31-8. PubMed ID: 19894081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.
    Call RJ; Burlison JD; Robertson JJ; Scott JR; Baker DK; Rossi MG; Howard SC; Hoffman JM
    J Pediatr; 2014 Sep; 165(3):447-52.e4. PubMed ID: 24768254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative.
    Takata GS; Taketomo CK; Waite S;
    Am J Health Syst Pharm; 2008 Nov; 65(21):2036-44. PubMed ID: 18945863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an electronic patient prioritization tool for clinical pharmacist interventions.
    Falconer N; Nand S; Liow D; Jackson A; Seddon M
    Am J Health Syst Pharm; 2014 Feb; 71(4):311-20. PubMed ID: 24481156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.
    Maříková M; Očovská Z; Nerad V; Kuběna AA; Blaha V; Vlček J
    Int J Clin Pharm; 2021 Oct; 43(5):1218-1226. PubMed ID: 33763812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.
    Hakkarainen KM; Gyllensten H; Jönsson AK; Andersson Sundell K; Petzold M; Hägg S
    Br J Clin Pharmacol; 2014 Jul; 78(1):170-83. PubMed ID: 24372506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety.
    Patel H; Gurumurthy P
    Int J Clin Pharm; 2019 Aug; 41(4):981-992. PubMed ID: 31240551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
    Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
    Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
    Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
    PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm.
    Seddon ME; Jackson A; Cameron C; Young ML; Escott L; Maharaj A; Miller N
    N Z Med J; 2012 Jan; 126(1368):9-20. PubMed ID: 23385830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.